Trial Profile
Long Term Efficacy of Rituximab in Patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Mar 2018 New trial record
- 16 Mar 2018 Results assessing long term persistence of rituximab (RTX) in a large observational RA cohort, were published in the Rheumatology.